US2022133288A1PendingUtilityA1

Micrograft for the treatment of intracranial aneurysms and method for use

Assignee: NEUROGAMI MEDICAL INCPriority: Jan 20, 2015Filed: Jan 14, 2022Published: May 5, 2022
Est. expiryJan 20, 2035(~8.5 yrs left)· nominal 20-yr term from priority
A61B 17/12172A61B 2017/00898A61F 2/07A61F 2/06A61B 17/12145A61B 2017/0053B29D 23/18A61B 2090/3966B29K 2067/003A61B 17/1215A61B 2017/00867A61B 17/12118A61B 17/12177A61B 2017/12054B29D 23/00B29K 2105/25A61B 17/1214A61F 2002/077A61B 17/12154A61B 2017/00526A61B 2017/00942A61B 17/0057B29K 2105/0035A61B 2090/0807A61B 2017/00893A61B 17/12031A61B 2017/1205A61B 17/12113A61B 2017/00778A61F 2/95
80
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A device for occluding a vasculature of a patient including a micrograft having an absorbent polymeric structure with a lumen of transporting blood. The micrograft has a series of peaks and valleys formed by crimping. The occluding device is sufficiently small and flexible to be tracked on a guidewire and/or pushed through a microcatheter to a site within the vasculature of the patient. Delivery systems for delivering the micrografts are also disclosed.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . A method of treating an intracranial aneurysm comprising the steps of:
 a) providing a polymeric occluding device having a lumen therein;   b) providing a delivery member supporting the occluding device;   c) inserting the delivery member with the occluding device into the intracranial aneurysm, the delivery member retaining the occluding device during delivery of the occluding device to the intracranial aneurysm;   d) leaving the occluding device in the intracranial aneurysm; and   e) delivering a blocking device into a vessel outside the intracranial aneurysm, the blocking device blocking exit of the occluding device from the intracranial aneurysm.   
     
     
         22 . The method of  claim 21 , further comprising the step of manipulating the delivery member to maneuver the occluding device within the intracranial aneurysm. 
     
     
         23 . The method of  claim 21 , wherein the occluding device has a permeable structure and blood enters the occluding device through a distal end of the lumen and through spaces in the permeable structure whereby the occluding device becomes saturated with blood and induces blood stagnation. 
     
     
         24 . The method of  claim 23 , wherein the occluding device has a preset curved shape and is delivered in a substantially linear configuration and moves to the curved shape when placed within the intracranial aneurysm. 
     
     
         25 . The method of  claim 21 , wherein the delivery member extends in a space between the blocking device and a wall of the vessel. 
     
     
         26 . The system of  claim 21 , wherein the blocking device is positioned on a delivery member proximal of the occluding device. 
     
     
         27 . The system of  claim 21 , wherein the delivery member extends through openings in the occluding device when the blocking device is in the vessel.

Join the waitlist — get patent alerts

Track US2022133288A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.